Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionankyrin binding

SPTB CLTC PLEC SPTBN4

9.33e-05232124GO:0030506
GeneOntologyMolecularFunctionligase activity

UBA5 WARS2 ACSL3 ADSS2 CAD GATC VARS2 NARS2 PARS2

1.04e-041742129GO:0016874
GeneOntologyBiologicalProcessepithelium development

PDE2A EPPK1 ABL2 MAP1B PPP1R12A LAMA1 CD109 RREB1 MET YAP1 DHCR7 PKD2 DLG3 TNFRSF19 KAZN PLEC USH2A GPAT4 TBX2 FLNB TIGAR SHROOM3 ZEB1 WNT1 WNT10B LIPN SPAG6 SHANK3 OPA1 TBX18 HHIP IGFBP5 DCHS1 PTCH2 ATM IHH CSMD1

6.09e-07146921737GO:0060429
GeneOntologyBiologicalProcesssensory organ development

SOX3 SP3 PDE6B LAMA1 KMT2C MIP USH2A SDK1 TBX2 ZEB1 WNT1 FAT3 WNT10B ZHX2 SPAG6 BBS10 TBX18 ATF6 DCHS1 SIX5 IHH MYO15A

9.85e-0673021722GO:0007423
GeneOntologyBiologicalProcessadult behavior

ABL2 SPTBN2 MET DMRT3 NRXN2 SDK1 CNTN2 GRIN2D SHANK3 WDR47 SPTBN4

1.07e-0520321711GO:0030534
GeneOntologyBiologicalProcessepithelial cell differentiation

PDE2A EPPK1 ABL2 MAP1B PPP1R12A LAMA1 CD109 MET YAP1 DHCR7 KAZN PLEC USH2A GPAT4 FLNB TIGAR SHROOM3 ZEB1 WNT1 WNT10B LIPN SPAG6 PTCH2 IHH

1.65e-0587021724GO:0030855
GeneOntologyBiologicalProcessmorphogenesis of an epithelium

ABL2 LAMA1 RREB1 MET YAP1 PKD2 DLG3 TBX2 SHROOM3 WNT1 SPAG6 SHANK3 OPA1 TBX18 HHIP IGFBP5 DCHS1 IHH CSMD1

3.19e-0561921719GO:0002009
GeneOntologyBiologicalProcessmesenchymal cell proliferation

DCHS2 TBX2 ZEB1 TBX18 DCHS1 IHH

3.58e-05592176GO:0010463
GeneOntologyBiologicalProcesstissue morphogenesis

ABL2 LAMA1 ACTG2 RREB1 MET YAP1 PKD2 DLG3 TBX2 SHROOM3 WNT1 SPAG6 SHANK3 OPA1 TBX18 HHIP IGFBP5 ARMC5 DCHS1 IHH CSMD1

4.64e-0575021721GO:0048729
GeneOntologyBiologicalProcessmyotube differentiation

HDAC4 BCL9 SORT1 MET NEO1 PLEC WNT1 WNT10B ANHX

6.19e-051642179GO:0014902
GeneOntologyBiologicalProcesscell-cell adhesion

DCHS2 ABL2 IRAK1 ITGA6 UBASH3A NEO1 FAT2 HMCN2 NRXN2 DLG3 SDK1 CNTN2 WNT1 FAT3 WNT10B VSIG10 OPA1 BTN2A1 TBX18 ARID2 TENM1 DCHS1 SIGLEC1 IHH PCDHGC3 CDH7

6.95e-05107721726GO:0098609
GeneOntologyBiologicalProcessgland development

SOX3 SP3 LAMA1 RREB1 JARID2 MET PKD2 GPAT4 TBX2 CAD WNT1 IGFBP5 ARMC5 ELK1 ATM IHH CSMD1

9.19e-0555821717GO:0048732
GeneOntologyBiologicalProcessmulti-pass transmembrane protein insertion into ER membrane

NOMO2 NOMO1 NOMO3

9.21e-0592173GO:0160063
GeneOntologyBiologicalProcesstRNA aminoacylation

WARS2 GATC VARS2 NARS2 PARS2

1.07e-04452175GO:0043039
GeneOntologyBiologicalProcessamino acid activation

WARS2 GATC VARS2 NARS2 PARS2

1.19e-04462175GO:0043038
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

SOX3 SP3 HDAC4 PPP1R12A ITGA6 RREB1 BCL9 MET KMT2C YAP1 PKD2 TBX2 NPM1 STRN3 ZEB1 ARID3A WNT1 WNT10B ZNF507 MLLT10 ARID3B KANSL3 ATF6 KMT2D ARID2 SIX5 ELK1 ATM DOT1L IHH

1.41e-04139021730GO:0045944
GeneOntologyBiologicalProcessepithelial tube morphogenesis

ABL2 LAMA1 MET YAP1 PKD2 TBX2 SHROOM3 WNT1 SHANK3 OPA1 HHIP DCHS1 IHH CSMD1

1.58e-0442121714GO:0060562
GeneOntologyBiologicalProcessanimal organ morphogenesis

SOX3 SP3 LAMA1 ITGA6 ACTG2 MET DMRT3 YAP1 PKD2 USH2A SDK1 TBX2 ZEB1 WNT1 FAT3 WNT10B ZHX2 SPAG6 SHANK3 BBS10 TBX18 HHIP IGFBP5 ARID2 DCHS1 IHH CSMD1 MYO15A

1.67e-04126921728GO:0009887
GeneOntologyBiologicalProcessmuscle cell differentiation

FBXO40 HDAC4 LAMA1 BCL9 SORT1 MET NEO1 PLEC TBX2 ZEB1 WNT1 WNT10B TBX18 IGFBP5 ANHX AKAP13

1.68e-0453121716GO:0042692
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

DCHS2 FAT2 HMCN2 SDK1 CNTN2 FAT3 DCHS1 PCDHGC3 CDH7

1.68e-041872179GO:0007156
GeneOntologyBiologicalProcessnegative regulation of cytoskeleton organization

MAP1B SPTB SPTBN2 MET CENATAC NPM1 SHANK3 WDR47 SPTBN4

2.22e-041942179GO:0051494
GeneOntologyBiologicalProcessbranching morphogenesis of an epithelial tube

LAMA1 MET YAP1 TBX2 WNT1 HHIP DCHS1 IHH CSMD1

2.58e-041982179GO:0048754
GeneOntologyCellularComponentsomatodendritic compartment

PDE2A ABL2 MAP1B SPTBN2 SORT1 GDPD5 MET NEO1 HMCN2 PTPRZ1 DLG3 GRIN3A PLEC USH2A CNTN2 FLNB STRN3 CAD FAT3 CIT SHANK3 OPA1 TRIM3 WDR47 SLC6A2 SPTBN4 LRP1 ELK1

8.31e-05122821828GO:0036477
GeneOntologyCellularComponentanchoring junction

DCHS2 EPPK1 PPP1R12A SPTBN2 LAMA1 ITGA6 FAT2 YAP1 MIP CLTC PKD2 DLG3 KAZN PLEC NPM1 FLNB SHROOM3 VSIG10 SPTBN4 ARMC5 LRP1 TNS1 PCDHGC3 CDH7

8.91e-0597621824GO:0070161
GeneOntologyCellularComponentmulti-pass translocon complex

NOMO2 NOMO1 NOMO3

8.97e-0592183GO:0160064
GeneOntologyCellularComponentspectrin

SPTB SPTBN2 SPTBN4

8.97e-0592183GO:0008091
GeneOntologyCellularComponenthemidesmosome

EPPK1 ITGA6 PLEC

1.74e-04112183GO:0030056
GeneOntologyCellularComponentneuronal cell body

MAP1B SPTBN2 SORT1 GDPD5 MET NEO1 HMCN2 PTPRZ1 DLG3 GRIN3A USH2A CNTN2 FLNB STRN3 CAD CIT WDR47 SLC6A2 SPTBN4 LRP1 ELK1

1.85e-0483521821GO:0043025
GeneOntologyCellularComponentcell body

MAP1B SPTBN2 ACTG2 SORT1 GDPD5 MET NEO1 HMCN2 PTPRZ1 DLG3 GRIN3A USH2A CNTN2 FLNB STRN3 CAD CIT WDR47 SLC6A2 SPTBN4 LRP1 ELK1

2.99e-0492921822GO:0044297
GeneOntologyCellularComponentER membrane insertion complex

NOMO2 NOMO1 NOMO3

3.74e-04142183GO:0072379
GeneOntologyCellularComponentcell-cell junction

DCHS2 EPPK1 SPTBN2 LAMA1 ITGA6 FAT2 YAP1 MIP PKD2 DLG3 KAZN SHROOM3 VSIG10 SPTBN4 PCDHGC3 CDH7

4.99e-0459121816GO:0005911
GeneOntologyCellularComponentnuclear matrix

KIF4A NPM1 CAD AHCTF1 SPTBN4 ARID2 TENM1

6.78e-041402187GO:0016363
Domain-

TRIM2 APEH TRIM3 HHIP TENM1 LRP1

5.30e-063921662.120.10.30
DomainACTININ_2

SPTB SPTBN2 PLEC FLNB SPTBN4

5.61e-06232165PS00020
DomainACTININ_1

SPTB SPTBN2 PLEC FLNB SPTBN4

5.61e-06232165PS00019
DomainActinin_actin-bd_CS

SPTB SPTBN2 PLEC FLNB SPTBN4

5.61e-06232165IPR001589
DomainDUF2012

NOMO2 NOMO1 NOMO3

6.05e-0642163PF09430
DomainSpectrin_bsu

SPTB SPTBN2 SPTBN4

6.05e-0642163IPR016343
DomainDUF2012

NOMO2 NOMO1 NOMO3

6.05e-0642163IPR019008
DomainCarboxyPept_regulatory_dom

NOMO2 CPXM2 NOMO1 NOMO3

1.15e-05132164IPR014766
Domain-

NOMO2 CPXM2 NOMO1 NOMO3

1.15e-051321642.60.40.1120
Domain6-blade_b-propeller_TolB-like

TRIM2 APEH TRIM3 HHIP TENM1 LRP1

1.42e-05462166IPR011042
DomainSpectrin_repeat

TRIO SPTB SPTBN2 PLEC SPTBN4

1.87e-05292165IPR002017
Domain-

JARID2 ARID3A ARID3B ARID2

2.15e-051521641.10.150.60
DomainBRIGHT

JARID2 ARID3A ARID3B ARID2

2.15e-05152164SM00501
DomainARID_dom

JARID2 ARID3A ARID3B ARID2

2.15e-05152164IPR001606
DomainARID

JARID2 ARID3A ARID3B ARID2

2.15e-05152164PS51011
DomainARID

JARID2 ARID3A ARID3B ARID2

2.15e-05152164PF01388
DomainSPEC

TRIO SPTB SPTBN2 PLEC SPTBN4

3.08e-05322165SM00150
DomainSpectrin/alpha-actinin

TRIO SPTB SPTBN2 PLEC SPTBN4

3.08e-05322165IPR018159
DomainCarboxyPept-like_regulatory

NOMO2 CPXM2 NOMO1 NOMO3

3.68e-05172164IPR008969
DomainLAM_G_DOMAIN

LAMA1 FAT2 NRXN2 USH2A FAT3

7.27e-05382165PS50025
DomainIg-like_fold

TRIO IGFBPL1 MET NEO1 HMCN2 NOMO2 PTPRZ1 PXDNL USH2A SDK1 CNTN2 FLNB COL6A3 TRIM2 VSIG10 BTN2A1 TRIM3 NOMO1 LRRN4CL SIGLEC1 NOMO3

7.45e-0570621621IPR013783
DomainCarb-bd-like_fold

NOMO2 NOMO1 NOMO3

8.18e-0582163IPR013784
Domain-

TRIO IGFBPL1 MET NEO1 NOMO2 PTPRZ1 PXDNL USH2A SDK1 CNTN2 FLNB COL6A3 TRIM2 VSIG10 BTN2A1 TRIM3 NOMO1 LRRN4CL SIGLEC1 NOMO3

9.19e-05663216202.60.40.10
DomainLaminin_G_2

LAMA1 FAT2 NRXN2 USH2A FAT3

9.35e-05402165PF02210
DomainCH

SPTB SPTBN2 PLEC FLNB LRCH2 SPTBN4

1.04e-04652166SM00033
DomainSpectrin

TRIO SPTB SPTBN2 SPTBN4

1.30e-04232164PF00435
DomainGSCR1_dom

BICRA BICRAL

1.33e-0422162IPR015671
DomainGLTSCR1

BICRA BICRAL

1.33e-0422162PF15249
DomainLamG

LAMA1 FAT2 NRXN2 USH2A FAT3

1.49e-04442165SM00282
DomainCH

SPTB SPTBN2 PLEC FLNB LRCH2 SPTBN4

1.58e-04702166PF00307
Domain-

SPTB SPTBN2 PLEC FLNB LRCH2 SPTBN4

1.71e-047121661.10.418.10
DomainIG_FLMN

FLNB TRIM2 TRIM3

1.72e-04102163SM00557
DomainCH

SPTB SPTBN2 PLEC FLNB LRCH2 SPTBN4

1.99e-04732166PS50021
DomainCH-domain

SPTB SPTBN2 PLEC FLNB LRCH2 SPTBN4

2.31e-04752166IPR001715
DomainFilamin

FLNB TRIM2 TRIM3

2.35e-04112163PF00630
DomainFILAMIN_REPEAT

FLNB TRIM2 TRIM3

2.35e-04112163PS50194
DomainFilamin/ABP280_rpt

FLNB TRIM2 TRIM3

2.35e-04112163IPR001298
DomainFilamin/ABP280_repeat-like

FLNB TRIM2 TRIM3

2.35e-04112163IPR017868
DomainAT_hook

KMT2C ZNF653 AHCTF1 DOT1L

2.48e-04272164SM00384
DomainAT_hook_DNA-bd_motif

KMT2C ZNF653 AHCTF1 DOT1L

2.48e-04272164IPR017956
DomainIg_I-set

TRIO IGFBPL1 NEO1 HMCN2 PXDNL SDK1 CNTN2 VSIG10 SIGLEC1

3.78e-041902169IPR013098
DomainI-set

TRIO IGFBPL1 NEO1 HMCN2 PXDNL SDK1 CNTN2 VSIG10 SIGLEC1

3.78e-041902169PF07679
DomainREKLES

ARID3A ARID3B

3.96e-0432162PS51486
DomainREKLES_domain

ARID3A ARID3B

3.96e-0432162IPR023334
DomainNHL

TRIM2 TRIM3 TENM1

4.00e-04132163PS51125
DomainHMGI/Y_DNA-bd_CS

KMT2C ZNF653 AHCTF1 DOT1L

4.28e-04312164IPR000637
DomainLaminin_G

LAMA1 FAT2 NRXN2 USH2A FAT3

5.50e-04582165IPR001791
DomainLaminin_N

LAMA1 USH2A LAMB4

7.64e-04162163IPR008211
DomainAT_hook

KMT2C AHCTF1 DOT1L

7.64e-04162163PF02178
DomainLamNT

LAMA1 USH2A LAMB4

7.64e-04162163SM00136
DomainLAMININ_NTER

LAMA1 USH2A LAMB4

7.64e-04162163PS51117
DomainLaminin_N

LAMA1 USH2A LAMB4

7.64e-04162163PF00055
DomainEGF_1

LAMA1 FAT2 HMCN2 NRXN2 USH2A LAMB4 FAT3 HHIP TENM1 LRP1

7.98e-0425521610PS00022
Domain-

LAMA1 FAT2 NRXN2 USH2A FAT3 NBEA

8.25e-049521662.60.120.200
DomainC1

DEF8 PRKD3 KMT2C CIT AKAP13

9.29e-04652165SM00109
DomainPE/DAG-bd

DEF8 PRKD3 KMT2C CIT AKAP13

9.96e-04662165IPR002219
DomainFYrich_C

KMT2C KMT2D

1.30e-0352162IPR003889
DomainFYrich_N

KMT2C KMT2D

1.30e-0352162IPR003888
DomainFYRC

KMT2C KMT2D

1.30e-0352162SM00542
DomainFYRN

KMT2C KMT2D

1.30e-0352162SM00541
DomainFYRN

KMT2C KMT2D

1.30e-0352162PF05964
DomainFYRC

KMT2C KMT2D

1.30e-0352162PF05965
DomainFYRC

KMT2C KMT2D

1.30e-0352162PS51543
DomainFYRN

KMT2C KMT2D

1.30e-0352162PS51542
DomainCadherin_CS

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

1.68e-031092166IPR020894
DomainIGc2

TRIO IGFBPL1 NEO1 HMCN2 PXDNL SDK1 CNTN2 VSIG10 SIGLEC1

1.70e-032352169SM00408
DomainIg_sub2

TRIO IGFBPL1 NEO1 HMCN2 PXDNL SDK1 CNTN2 VSIG10 SIGLEC1

1.70e-032352169IPR003598
Domain-

EPPK1 PLEC

1.94e-03621623.90.1290.10
DomainQuino_amine_DH_bsu

TRIM2 LRRK1 TRIM3

2.00e-03222163IPR011044
DomainEPHD

KMT2C MLLT10 KMT2D

2.00e-03222163PS51805
DomainCADHERIN_1

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.02e-031132166PS00232
DomainCadherin

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.02e-031132166PF00028
DomainCADHERIN_2

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.11e-031142166PS50268
Domain-

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.11e-0311421662.60.40.60
DomainCA

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.21e-031152166SM00112
DomainCadherin-like

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.31e-031162166IPR015919
DomainCadherin

DCHS2 FAT2 FAT3 DCHS1 PCDHGC3 CDH7

2.51e-031182166IPR002126
DomainClathrin

CLTC VPS18

2.69e-0372162PF00637
DomainGP_PDE_dom

GDPD5 GDPD4

2.69e-0372162IPR030395
DomainPlectin

EPPK1 PLEC

2.69e-0372162PF00681
DomainGlyceroP-diester-Pdiesterase

GDPD5 GDPD4

2.69e-0372162IPR004129
DomainSIX1_SD

ANHX SIX5

2.69e-0372162IPR031701
DomainGDPD

GDPD5 GDPD4

2.69e-0372162PF03009
DomainPlectin_repeat

EPPK1 PLEC

2.69e-0372162IPR001101
DomainSIX1_SD

ANHX SIX5

2.69e-0372162PF16878
DomainCHCR

CLTC VPS18

2.69e-0372162PS50236
DomainGAF

PDE2A PDE6B

2.69e-0372162PF01590
DomainGP_PDE

GDPD5 GDPD4

2.69e-0372162PS51704
DomainPLEC

EPPK1 PLEC

2.69e-0372162SM00250
PathwayREACTOME_L1CAM_INTERACTIONS

SPTB SPTBN2 LAMA1 KIF4A CLTC DLG3 CNTN2 SPTBN4

3.85e-051211478M872
PathwayREACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION

WARS2 VARS2 NARS2 PARS2

5.92e-05211474M15096
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

PDE2A EPPK1 TRIO IRAK1 BCL9 GDPD5 KMT2C TMEM132A MTMR3 PLEC GPAT4 SHROOM3 ARID3A BICRA WWP1 APEH MIB2 LRRK1 GRIN2D MLLT10 MED13L FAAP100 CIT C2CD2 EML3 KANSL3 KMT2D AKAP13 DOT1L HR

2.17e-1111052203035748872
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

PDE2A HDAC4 TRIO PPP1R12A SPTBN2 KIF4A BCL9 CLTC DLG3 NPM1 STRN3 SHROOM3 CAD ZEB1 LRCH2 NBEA GRIN2D CIT VIRMA SHANK3 OPA1 TRIM3 WDR47 SPTBN4 DCHS1 LRP1 TNS1 LRRFIP1

2.23e-119632202828671696
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

IRAK1 RREB1 KMT2C HMBOX1 NPM1 ZEB1 BICRA NCKIPSD APEH ZHX2 ARID3B KMT2D ARID2 SIX5 ELK1 BICRAL DOT1L MYO15A

1.05e-103982201835016035
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

PDE2A MAP1B TRIO PPP1R12A SPTB SPTBN2 HDHD2 NRXN2 PTPRZ1 CLTC DLAT DLG3 PLEC CNTN2 NPM1 FLNB STRN3 VPS18 CAD LRCH2 NCKIPSD NBEA CIT VIRMA SHANK3 OPA1 TRIM3 ALG2 WDR47 SPTBN4 TNS1 LRRFIP1

5.94e-1014312203237142655
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

BDP1 HDAC4 MAP1B TRIO PPP1R12A SPTB KMT2C PKD2 TNFRSF19 CENATAC MOCOS HMBOX1 FLNB TIGAR SHROOM3 HYKK BICRA WWP1 ZHX2 C2CD2 DNAH1 KANSL3 SPTBN4 ATF6 FAM13A LRP1 AKAP13 PNPLA7 CSMD1 CATSPERG SH3RF3 NBR1

1.57e-0914892203228611215
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

SP3 EPPK1 HDAC4 BCL9 ZNF469 YAP1 CLTC PLEC TECPR1 SHROOM3 BICRA MLLT10 ARID2 AKAP13 ATM ZKSCAN4 LRRFIP1

2.69e-094302201735044719
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

DCHS2 FAT2 FAT3 DCHS1

5.37e-087220416059920
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

MAP1B TRIO ACSL3 MET NEO1 DHCR7 CLTC DLAT EMC10 DLG3 PLEC NPM1 FLNB STRN3 CAD NBEA MIB2 CIT SHANK3 OPA1 WDR47 DNAJC11 TENM1 SLC25A52 LRRFIP1

7.57e-0811392202536417873
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

EPPK1 PPP1R12A SPTBN2 IRAK1 ITGA6 ACTG2 ACSL3 CLTC DLAT PLEC NPM1 FLNB SHROOM3 CAD OPA1 LRRFIP1

7.79e-084772201631300519
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

GALK1 MAP1B PPP1R12A SPTBN2 IRAK1 KIF4A KMT2C YAP1 CLTC ZNF598 CAD AHCTF1 ARID3B KMT2D ARID2 DOT1L LRRFIP1

9.49e-085492201738280479
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DCHS2 PDE2A TRIO SPTB SPTBN2 DEF8 QRICH1 UBASH3A NOMO2 CLTC MTMR3 DLAT PLEC BRWD1 FLNB APEH NBEA MED13L CIT WDR47 SPTBN4 ATF6 HEATR6 LRP1 ATM LRRFIP1

1.99e-0712852202635914814
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

GALK1 ACTR5 PPP1R12A IRAK1 RREB1 POLR1G ZNF469 HMCN2 DLAT TBX2 BRWD1 NPM1 BICRA CFAP36 WWP1 FAT3 AHCTF1 OPA1 PARS2 ARID2 LRP1 BICRAL SIGLEC1 CSMD1

2.04e-0711162202431753913
Pubmed

Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.

NOMO2 NOMO1 NOMO3

2.50e-073220336011023
Pubmed

Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.

NOMO2 NOMO1 NOMO3

2.50e-073220325576386
Pubmed

Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.

HDAC4 SPTB PANK1 YAP1 CLTC NPM1 CAD WWP1 VIRMA AKAP13

4.12e-071902201015161933
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

MAP1B ORC3 PPP1R12A KIF4A QRICH1 SORT1 ZNF598 TBX2 ARID3A FAAP100 TRIM3 PARS2 ARID3B WDR47 KANSL3 ATF6 KMT2D LRP1 SIX5 NBR1

6.40e-078572202025609649
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

TRIO DHCR7 CLTC PLEC NPM1 FLNB CAD CIT HEATR6 AKAP13

7.22e-072022201033005030
Pubmed

Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

NOMO2 NOMO1 NOMO3

9.94e-074220331833031
Pubmed

A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.

NOMO2 NOMO1 NOMO3

9.94e-07422039267806
Pubmed

GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.

POLR1G BICRA ATM

9.94e-074220330128886
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

PPP1R12A LAMA1 FAT2 CLTC PLEC FLNB CAD FAT3 VIRMA KMT2D

2.72e-062342201036243803
Pubmed

Interaction network of human early embryonic transcription factors.

HDAC4 RREB1 BCL9 SORT1 KMT2C TBX2 ZEB1 ARID3A BICRA ZHX2 KMT2D ARID2

2.81e-063512201238297188
Pubmed

YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme.

ACTG2 YAP1 HHIP PTCH2 IHH

3.11e-0636220528943241
Pubmed

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

TRIO LAMA1 CD109 KAZN USH2A AKAP13 CSMD1

3.83e-06101220718519826
Pubmed

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.

SPTB SPTBN2 FLNB SPTBN4

4.45e-0618220412119179
Pubmed

Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.

DCHS2 FAT2 FAT3 DCHS1

4.45e-0618220433108146
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

PDE2A TRIO SPTBN2 DLG3 NBEA GRIN2D CIT SHANK3 SPTBN4 LRP1

5.07e-062512201027507650
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

HDAC4 ORC3 KIF4A QRICH1 RREB1 BCL9 KMT2C CLTC CAD ARID3A BICRA ZNF507 APEH MED13L CIT ARID3B KANSL3 KMT2D ARID2 BICRAL ZKSCAN4

8.06e-0611032202134189442
Pubmed

LPCAT3 Is Transcriptionally Regulated by YAP/ZEB/EP300 and Collaborates with ACSL4 and YAP to Determine Ferroptosis Sensitivity.

YAP1 ZEB1 KMT2D

8.58e-067220337166352
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

MCMBP SPTBN2 ACSL3 MET NEO1 NOMO2 DHCR7 CLTC DLAT EMC10 GPAT4 NPM1 TIGAR SHROOM3 CAD AHCTF1 GATC APEH VARS2 NOMO1 ATF6 DNAJC11 AKAP13 ATM NBR1

9.23e-0614872202533957083
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

GALK1 EPPK1 ORC3 KIF4A RREB1 CLTC PLEC NPM1 FLNB EML3 ARID2

9.84e-063322201132786267
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

RREB1 BCL9 POLR1G ACSL3 YAP1 CLTC PLEC MOCOS STRN3 ZEB1 ZNF507 VIRMA KANSL3 KMT2D FAM13A ATM LRRFIP1

1.01e-057742201715302935
Pubmed

NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.

EPPK1 PPP1R12A SPTBN2 AK7 CLTC PLEC NPM1 FLNB VIRMA TRBV13 LRRFIP1

1.01e-053332201132665550
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

SP3 ACTR5 ORC3 SLC39A11 PPP1R12A NOL6 KIF4A POLR1G JARID2 KMT2C DLG3 ZNF598 TBX2 STRN3 SHROOM3 CAD AHCTF1 ZHX2 CIT VIRMA NOMO1 IGFBP5 ARID2 DNAJC11 IMP3

1.03e-0514972202531527615
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

ABL2 TRIO SPTBN2 CLTC DLG3 NBEA GRIN2D CIT SHANK3 OPA1

1.36e-052812201028706196
Pubmed

Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.

NOMO2 NOMO1 NOMO3

1.37e-058220315257293
Pubmed

A human MAP kinase interactome.

ABL2 HDAC4 SPTBN2 KMT2C CLTC PLEC BICRA CFAP36 ATF6 ARID2 AKAP13 BICRAL TNS1

1.52e-054862201320936779
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

MCMBP HDAC4 PPP1R12A KIF4A ADSS2 YAP1 DHCR7 CLTC DLAT ZNF598 HMBOX1 NPM1 VPS18 CAD WWP1 APEH MED13L CIT OPA1 DNAH1 DNAJC11 DOT1L

1.58e-0512472202227684187
Pubmed

Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.

PPP1R12A SPTB SPTBN2 HDHD2 NPM1 SHANK3 OPA1 TRIM3 LRRFIP1

1.93e-05233220929518331
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

EPPK1 MAP1B SPTBN2 NOL6 KIF4A ACSL3 CLTC DLAT PLEC NPM1 FLNB CAD AHCTF1 VIRMA ATM

2.02e-056532201522586326
Pubmed

Substrate-driven assembly of a translocon for multipass membrane proteins.

NOMO2 NOMO1 NOMO3

2.04e-059220336261522
Pubmed

Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.

DCHS2 PPP1R12A YAP1 DCHS1

2.09e-0526220421303848
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

MCMBP KIF4A POLR1G PRKD3 YAP1 MOCOS FLNB STRN3 CAD AHCTF1 FAM13A AKAP13 LRRFIP1

2.18e-055032201316964243
Pubmed

Nomenclature of the ARID family of DNA-binding proteins.

ARID3A ARID3B ARID2

2.90e-0510220315922553
Pubmed

Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.

HDAC4 HHIP FAM13A LRP1 TNS1

3.38e-0558220523284291
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

MAP1B TRIO ITGA6 POLR1G KMT2C ADSS2 STRN3 LRCH2 NCKIPSD APEH SPAG6 SHANK3 AKAP13 CATSPERG LRRFIP1

3.74e-056892201536543142
Pubmed

An ER translocon for multi-pass membrane protein biogenesis.

NOMO2 NOMO1 NOMO3

3.97e-0511220332820719
Pubmed

Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin.

SPTB SPTBN2 SPTBN4

3.97e-0511220317607528
Pubmed

USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

EPPK1 BCL9 PLEC

3.97e-0511220331073027
Pubmed

hDOT1L links histone methylation to leukemogenesis.

MLLT10 DOT1L

3.98e-052220215851025
Pubmed

Transcriptomic Analysis of Lung Tissue from Cigarette Smoke-Induced Emphysema Murine Models and Human Chronic Obstructive Pulmonary Disease Show Shared and Distinct Pathways.

HHIP FAM13A

3.98e-052220228248572
Pubmed

Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding.

ITGA6 PLEC

3.98e-052220210525545
Pubmed

Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer.

MET TIGAR

3.98e-052220229753331
Pubmed

Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1).

YAP1 LRP1

3.98e-052220229138479
Pubmed

Genome-wide association study on the FEV1/FVC ratio in never-smokers identifies HHIP and FAM13A.

HHIP FAM13A

3.98e-052220227612410
Pubmed

Selective down-regulation of the alpha6-integrin subunit in melanocytes by UVB light.

LAMA1 ITGA6

3.98e-052220215885076
Pubmed

PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.

NARS2 PARS2

3.98e-052220228077841
Pubmed

Structural and functional analysis of the actin binding domain of plectin suggests alternative mechanisms for binding to F-actin and integrin beta4.

ITGA6 PLEC

3.98e-052220212791251
Pubmed

Synapse associated protein 102 (SAP102) binds the C-terminal part of the scaffolding protein neurobeachin.

DLG3 NBEA

3.98e-052220222745750
Pubmed

AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.

MLLT10 DOT1L

3.98e-052220234215314
Pubmed

The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family.

ARID3A ARID3B

3.98e-05222028543152
Pubmed

Opposing roles of ZEB1 in the cytoplasm and nucleus control cytoskeletal assembly and YAP1 activity.

YAP1 ZEB1

3.98e-052220236198275
Pubmed

Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome.

NARS2 PARS2

3.98e-052220225629079
Pubmed

The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.

KMT2C KMT2D

3.98e-052220234156443
Pubmed

ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.

ARID3A ARID3B

3.98e-052220232061921
Pubmed

Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.

MET PTPRZ1

3.98e-052220225935522
Pubmed

Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.

KMT2C KMT2D

3.98e-052220227280393
Pubmed

Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting.

MET LRP1

3.98e-052220228724630
Pubmed

Association analyses of the interaction between the ADSS and ATM genes with schizophrenia in a Chinese population.

ADSS2 ATM

3.98e-052220219115993
Pubmed

Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.

KMT2C KMT2D

3.98e-052220236869380
Pubmed

Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.

MET PTPRZ1

3.98e-052220228504721
Pubmed

Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.

YAP1 ATM

3.98e-052220224810048
Pubmed

Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function.

MET PTPRZ1

3.98e-052220221454675
Pubmed

Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.

PADI4 ELK1

3.98e-052220227176594
Pubmed

Plakins in development and disease.

EPPK1 PLEC

3.98e-052220217499243
Pubmed

KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.

KMT2C KMT2D

3.98e-052220231924266
Pubmed

RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.

MET PTPRZ1

3.98e-052220225135958
Pubmed

Nucleophosmin 1 cooperates with the methyltransferase DOT1L to preserve peri-nucleolar heterochromatin organization by regulating H3K27me3 levels and DNA repeats expression.

NPM1 DOT1L

3.98e-052220237759327
Pubmed

Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.

ADRA1D SLC6A2

3.98e-052220217404580
Pubmed

Hedgehog Signaling Controls Chondrogenesis and Ectopic Bone Formation via the Yap-Ihh Axis.

YAP1 IHH

3.98e-052220238540766
Pubmed

Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.

MLLT10 DOT1L

3.98e-052220219443658
Pubmed

Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.

KMT2C KMT2D

3.98e-052220228967912
Pubmed

MAP1B Interaction with the FW Domain of the Autophagic Receptor Nbr1 Facilitates Its Association to the Microtubule Network.

MAP1B NBR1

3.98e-052220222654911
Pubmed

High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.

MET PTPRZ1

3.98e-052220233645009
Pubmed

Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.

YAP1 ZEB1

3.98e-052220232692442
Pubmed

Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.

KMT2C KMT2D

3.98e-052220236601880
Pubmed

Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.

KMT2C KMT2D

3.98e-052220228483418
Pubmed

Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.

TRIM2 IGFBP5

3.98e-052220217290407
Pubmed

AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

MLLT10 DOT1L

3.98e-052220225464900
Pubmed

Distribution of alpha 6 integrin subunit in developing mouse submandibular gland.

LAMA1 ITGA6

3.98e-05222028409377
Pubmed

Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c-Met to up-regulate angiogenesis and lung adenocarcinoma growth.

MET PTPRZ1

3.98e-052220237260355
Pubmed

Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.

YAP1 ZEB1

3.98e-052220233421513
Pubmed

Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma.

SPTB SPTBN2

3.98e-052220230798076
Pubmed

HDAC4 regulates neuronal survival in normal and diseased retinas.

HDAC4 PDE6B

3.98e-052220219131628
Pubmed

Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.

IGFBP5 SH3RF3

3.98e-052220217823924
Pubmed

Dot1l cooperates with Npm1 to repress endogenous retrovirus MERVL in embryonic stem cells.

NPM1 DOT1L

3.98e-052220237522386
Pubmed

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types.

YAP1 ZEB1

3.98e-052220226876920
Pubmed

A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.

PDE6B OPA1

3.98e-052220217314202
Pubmed

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.

MET TIGAR

3.98e-052220221057531
Pubmed

Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.

KMT2C KMT2D

3.98e-052220225346535
InteractionTEAD1 interactions

RREB1 KMT2C UBTD1 YAP1 ZEB1 ARID3A ZHX2 CIT TRIM3 ARID3B KMT2D ARID2 ZKSCAN4

4.97e-0817621313int:TEAD1
InteractionFEV interactions

RREB1 BCL9 KMT2C YAP1 ZEB1 ARID3A BICRA MLLT10 ZHX2 KMT2D ARID2 SIX5 ZKSCAN4

2.63e-0720321313int:FEV
InteractionTOP3B interactions

PDE2A EPPK1 HDAC4 TRIO SPTB SPTBN2 IRAK1 BCL9 GDPD5 KMT2C TMEM132A MTMR3 DLAT PLEC ZNF598 GPAT4 SHROOM3 CAD ARID3A BICRA WWP1 APEH MIB2 LRRK1 GRIN2D MLLT10 MED13L FAAP100 CIT C2CD2 EML3 KANSL3 KMT2D AKAP13 DOT1L HR

1.85e-06147021336int:TOP3B
InteractionPAX6 interactions

SOX3 QRICH1 RREB1 BCL9 KMT2C KCTD7 HMBOX1 ZEB1 ARID3A BICRA ZHX2 SHANK3 ARID3B KMT2D ARID2 ZKSCAN4

1.90e-0636621316int:PAX6
InteractionCRX interactions

SOX3 SP3 QRICH1 RREB1 BCL9 SORT1 KMT2C ARID3A BICRA ZHX2 KMT2D ARID2 ATM

3.28e-0625421313int:CRX
InteractionNFIX interactions

QRICH1 RREB1 KMT2C ZEB1 ARID3A BICRA ZHX2 ARID3B KANSL3 KMT2D ARID2 ZKSCAN4

5.67e-0622721312int:NFIX
InteractionHNF1B interactions

BCL9 KMT2C YAP1 HMBOX1 ZEB1 ARID3A BICRA MLLT10 ARID3B KMT2D ARID2

5.92e-0619021311int:HNF1B
InteractionKLF5 interactions

ACTR5 BCL9 KMT2C YAP1 ARID3A WWP1 MLLT10 ZHX2 ARID3B KMT2D ARID2

7.58e-0619521311int:KLF5
InteractionBAG2 interactions

ABL2 HDAC4 MAP1B PPP1R12A IRAK1 QRICH1 RREB1 YAP1 DHCR7 CLTC ZNF598 NPAS1 KCTD7 NPM1 LRRK1 CIT VIRMA DNAJC11 ELK1 DOT1L

1.06e-0562221320int:BAG2
InteractionKCTD13 interactions

PDE2A MAP1B TRIO PPP1R12A SPTB SPTBN2 HDHD2 NRXN2 PTPRZ1 CLTC DLAT DLG3 PLEC CNTN2 NPM1 FLNB LAMB4 STRN3 VPS18 CAD LRCH2 NCKIPSD NBEA CIT VIRMA SHANK3 OPA1 TRIM3 ALG2 WDR47 SPTBN4 TNS1 LRRFIP1

1.08e-05139421333int:KCTD13
InteractionPKD1P1 interactions

UBA5 HMBOX1 VIRMA

1.15e-0552133int:PKD1P1
InteractionSRF interactions

HDAC4 HMBOX1 ZEB1 ZHX2 ARID3B ATF6 ARID2 SIX5 ELK1

1.74e-051392139int:SRF
InteractionIHH interactions

HHIP PTCH2 IHH

2.27e-0562133int:IHH
InteractionLHX6 interactions

QRICH1 BCL9 ZEB1 ZNF507 ARID3B ARID2

3.33e-05582136int:LHX6
InteractionFSCN2 interactions

QRICH1 ZNF507 VIRMA

3.95e-0572133int:FSCN2
InteractionWWTR1 interactions

GALK1 MAP1B PPP1R12A IRAK1 YAP1 CLTC PKD2 ZNF598 TBX2 ZEB1 AHCTF1 ARID3B KMT2D ARID2 LRRFIP1

4.57e-0542221315int:WWTR1
InteractionLRRC31 interactions

TRIO DHCR7 CLTC PLEC NPM1 FLNB CAD CIT HEATR6 AKAP13

6.80e-0520521310int:LRRC31
InteractionSOX9 interactions

BCL9 KMT2C ARID3A VIRMA ARID3B KMT2D ARID2

7.67e-05972137int:SOX9
InteractionGRIN2B interactions

MET DHCR7 CLTC DLG3 GRIN3A MIB2 CIT SHANK3 LRP1

8.44e-051702139int:GRIN2B
GeneFamilyAT-rich interaction domain containing

JARID2 ARID3A ARID3B ARID2

5.06e-06151454418
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

TRIO IGFBPL1 NEO1 HMCN2 PXDNL SDK1 CNTN2 VSIG10 SIGLEC1

6.07e-061611459593
GeneFamilyCadherin related

DCHS2 FAT2 FAT3 DCHS1

8.71e-0617145424
GeneFamilyEF-hand domain containing|Spectrins

SPTB SPTBN2 SPTBN4

1.73e-05714531113
GeneFamilyGlutamate ionotropic receptor NMDA type subunits

GRIN3A GRIN2D

1.31e-03714521201
GeneFamilyEF-hand domain containing|Plakins

EPPK1 PLEC

1.73e-0381452939
GeneFamilyFibronectin type III domain containing

NEO1 PTPRZ1 USH2A SDK1 CNTN2 LRRN4CL

1.85e-031601456555
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

KMT2C KMT2D DOT1L

2.52e-03341453487
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

MAP1B PPP1R12A DLG3 PCIF1 CSMD1 TNS1

3.42e-031811456694
GeneFamilyLaminin subunits

LAMA1 LAMB4

4.00e-03121452626
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

SP3 HDAC4 MAP1B TRIO PPP1R12A ITGA6 ACSL3 JARID2 YAP1 PKD2 MTMR3 KAZN FLNB STRN3 ZEB1 TRIM2 WWP1 AHCTF1 MED13L ZHX2 C2CD2 OPA1 AKAP13 BICRAL LRRFIP1

6.85e-0885622025M4500
CoexpressionGSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP

SOX3 PDE6B SPTBN2 DEF8 SPSB2 TCAF2 CPXM2 WNT10B SLC6A2 IGFBP5

7.94e-0620022010M9562
CoexpressionGSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP

TRIO DEF8 ITGA6 QRICH1 PLEC ZNF653 BRWD1 MIB2 KANSL3 TNS1

7.94e-0620022010M6988
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

SLC39A11 PPP1R12A ACTG2 SORT1 HMCN2 YAP1 PKD2 SDK1 TBX2 FLNB CPXM2 FAT3

1.35e-1018322012818fd886e0188091310825f9145fa53328f2c979
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

PPP1R12A ACTG2 SORT1 HMCN2 YAP1 PKD2 SDK1 FLNB SHROOM3 CPXM2 FAT3 LRRFIP1

1.85e-101882201234e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 USH2A SDK1 CNTN2 FAT3 SLC35F1 DNAH1 GUCY2F TENM1 CSMD1 MYO15A

2.15e-09184220112cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 USH2A SDK1 CNTN2 FAT3 SLC35F1 DNAH1 GUCY2F TENM1 CSMD1 MYO15A

2.15e-09184220112b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA1 USH2A SDK1 CNTN2 FAT3 SLC35F1 DNAH1 GUCY2F TENM1 CSMD1 MYO15A

2.15e-0918422011ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

PPP1R12A ACTG2 SORT1 HMCN2 YAP1 PKD2 SDK1 FLNB SHROOM3 CPXM2 FAT3

2.84e-09189220116b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

SLC39A11 PPP1R12A ACTG2 SORT1 HMCN2 YAP1 SDK1 FLNB CPXM2 FAT3

2.76e-0818322010cae2ee08f985a6f005b4b8e959e465350315156a
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACTG2 PXDNL TNFRSF19 SDK1 FAT3 HHIP IGFBP5 LRP1 GASK1A

4.84e-07191220914057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TRIO ACSL3 PTPRZ1 TNFRSF19 SHROOM3 ZEB1 FAT3 LRP1 PCDHGC3

5.51e-0719422098b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCellwk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

DCHS2 ZNF653 VWA5B1 TBX2 COL6A3 FAT3 DCHS1 LRP1

1.79e-06166220865dafed953b01a9830b54309af75c7a561e88336
ToppCellAdult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor

GPR146 GDPD5 NOMO2 ZEB1 PRSS57 SHANK3 DCHS1 CSMD1

2.65e-0617522080a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MAP1B ACTG2 ADRA1D PXDNL SLC35F1 TBX18 IGFBP5 CSMD1

3.01e-061782208066dbc4cc2083c549d98122ed44707127f34d582
ToppCellwk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

SLC39A11 PTPRZ1 MTMR3 ZNF653 CPXM2 DNAH1 WDR47 CDH7

3.01e-061782208a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

MAP1B ACTG2 PXDNL CPXM2 FAT3 IGFBP5 TNS1 SH3RF3

3.27e-061802208d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellAdult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor

MAP1B SPTB ADRA1D TBX2 NCKIPSD KCP TNS1 SH3RF3

3.69e-061832208fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG3 CENATAC COL6A3 CPXM2 TBX18 LRP1 DOT1L TNS1

4.00e-06185220838486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCellCOVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A CD109 TCAF2 ZEB1 SHANK3 IGFBP5 TNS1 SH3RF3

4.00e-061852208673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLG3 CENATAC COL6A3 CPXM2 TBX18 LRP1 DOT1L TNS1

4.00e-0618522083c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PDE2A ADRA1D PXDNL TBX2 COL6A3 KCP NBEA SLC35F1

4.33e-061872208fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCellAdult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor

MAP1B SPTB ADRA1D TBX2 COL6A3 KCP TNS1 SH3RF3

4.33e-06187220862759efb660179402fb574ce5701c89a2e17bcfe
ToppCelldroplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXO40 MAP1B CD109 ACTG2 ADRA1D PTPRZ1 TBX18 IHH

4.51e-06188220861f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCelldroplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBXO40 MAP1B CD109 ACTG2 ADRA1D PTPRZ1 TBX18 IHH

4.51e-0618822087553ef7de3575af4cf34704b405b551c1af8eb83
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MAP1B ACTG2 TNFRSF19 FAT3 HHIP IGFBP5 LRP1 GASK1A

4.69e-06189220845e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1B ACTG2 TNFRSF19 COL6A3 HHIP IGFBP5 FAM13A CSMD1

4.69e-0618922086e83bf855d4771885b60bb8992df2f9b508eef97
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1B ACTG2 TNFRSF19 COL6A3 HHIP IGFBP5 FAM13A CSMD1

4.69e-061892208cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1B ACTG2 TNFRSF19 COL6A3 HHIP IGFBP5 FAM13A CSMD1

4.69e-061892208102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HDAC4 SPTBN2 ITGA6 KAZN VWA5B1 TBX2 SHROOM3 TRIM2

4.87e-061902208b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD109 BCL9 PRSS36 VARS2 C2CD2 DNAH1 ATM ZKSCAN4

4.87e-06190220863018acb7ad80415e861643162abdc2e55968ee4
ToppCellfacs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B CD109 ACTG2 PKD2 COL6A3 HHIP IGFBP5 CSMD1

4.87e-061902208c7bd087f36321cec61b98657433b4d19d135791f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B CD109 ACTG2 PKD2 COL6A3 HHIP IGFBP5 CSMD1

4.87e-061902208834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCellMesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

MAP1B SPTB ACTG2 ADRA1D TBX2 SLC35F1 IGFBP5 CSMD1

5.06e-061912208fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX3 PTPRZ1 GRIN3A NPAS1 SLC35F1 GUCY2F LRP1 PCDHGC3

5.06e-061912208ece87127f85939e61b1048d968ed96f0e87c3a79
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX3 PTPRZ1 GRIN3A NPAS1 SLC35F1 GUCY2F LRP1 PCDHGC3

5.06e-061912208478e8341ee03b05501e2233e02cef5f97492c95d
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO MET ZHX2 SPAG6 AKAP13 DOT1L SH3RF3 LRRFIP1

5.26e-0619222088b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FBXO40 MAP1B CD109 ACTG2 ADRA1D TNFRSF19 HHIP IGFBP5

5.26e-0619222082cc712186e37fb21a964c032765c36a8b4a852cf
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

MAP1B YAP1 TNFRSF19 KAZN TBX2 COL6A3 ZEB1 SH3RF3

5.47e-061932208e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

BDP1 ACSL3 JARID2 TNFRSF19 SDK1 HMBOX1 MED13L ARID2

5.47e-061932208e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellCOVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A CD109 HMBOX1 TCAF2 ZEB1 SHANK3 IGFBP5 SH3RF3

5.68e-061942208660535b492445063d965095a50e1e299ce04c50a
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1B CD109 ACTG2 TBX2 COL6A3 HHIP IGFBP5 CSMD1

5.90e-061952208c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MAP1B CD109 ACTG2 TBX2 COL6A3 HHIP IGFBP5 CSMD1

5.90e-061952208ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MAP1B SPTB ACTG2 HMCN2 SDK1 TBX18 IGFBP5 SH3RF3

6.35e-0619722083332b9b5bf78f0203ebbd94257a36e9054d896c3
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DCHS2 MAP1B TBX2 COL6A3 ZEB1 TENM1 SH3RF3 GASK1A

6.35e-06197220844673c38384453207871d3fd8e8ba9093cc06bc5
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MAP1B ACTG2 HMCN2 PKD2 CPXM2 FAT3 IGFBP5 SH3RF3

6.35e-061972208bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCellSkin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.

DCHS2 ACTG2 ADRA1D TMEM132A TBX2 WNT1 IGFBP5 TNS1

6.84e-061992208bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9

SPTBN2 NOL6 POLR1G ENOPH1 MET TMEM132A CAD GRIN2D

6.84e-06199220885b3b1ad01368dae4adbc9da7efc148e49992f69
ToppCellTCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9

SPTBN2 NOL6 POLR1G ENOPH1 MET TMEM132A CAD GRIN2D

6.84e-061992208c7d6a8398f2419b726a0461585d1ee0561654e3b
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ABL2 CD109 JARID2 KMT2C FLNB AKAP13 TNS1 LRRFIP1

6.84e-061992208379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MAP1B PKD2 SDK1 TBX2 COL6A3 FAT3 LRP1 SH3RF3

7.10e-062002208389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MAP1B PPP1R12A ACTG2 SORT1 TBX2 IGFBP5 TNS1 LRRFIP1

7.10e-0620022088b80a65b69b36ed405214564b939452c90aa40d6
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

MAP1B PPP1R12A ACTG2 SORT1 TBX2 IGFBP5 TNS1 LRRFIP1

7.10e-0620022082bc7f462a551292de2501028164573935232f899
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPTBN2 IRAK1 HDHD2 GPR146 TECPR1 KMT2D PTCH2

7.23e-06143220792ddc3e3f6ba78dd9daeb272c12503ec2650a874
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells)

BDP1 HDAC4 UBASH3A UBTD1 TECPR1 STRN3 OPA1

9.46e-06149220741f28138bde45d0b814e116837e5a32b5e80d54a
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ACTG2 MET TBX2 COL6A3 ZEB1 FAT3 HHIP

1.33e-051572207b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ACTG2 HMCN2 PTPRZ1 CPXM2 PTCHD4 HHIP IGFBP5

1.50e-0516022078624f101828efd32cdd38a65df8d94d690720a63
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ACTG2 HMCN2 PTPRZ1 CPXM2 PTCHD4 HHIP IGFBP5

1.50e-0516022079de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

EPPK1 MAP1B PPP1R12A ACTG2 HMCN2 TBX2 FAT3

1.57e-05161220747b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells)

SLC35G6 FAT2 YAP1 PLA2G4F VSIG10 HHIP AKAP13

1.76e-051642207d005cfd821b87548b075120bffe65a0be9860463
ToppCell343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells)

SLC35G6 FAT2 YAP1 PLA2G4F VSIG10 HHIP AKAP13

1.76e-051642207beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32

ABL2 LAMA1 ZMYND15 COL6A3 PRSS57 CPXM2

2.19e-051142206f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32

ABL2 LAMA1 ZMYND15 COL6A3 PRSS57 CPXM2

2.19e-0511422067be16e7f7b9c9dbd68933ace3b7f8f661bed41a7
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor

MAP1B SPTB ACTG2 ADRA1D TBX2 TBX18 IGFBP5

2.40e-051722207c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCellCOVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type

SPTBN2 ITGA6 KAZN VWA5B1 SHROOM3 TRIM2 IGFBP5

2.78e-05176220745028197364c64e93e3ffe86aff773d47a477d49
ToppCellChildren_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SPTB ADRA1D TBX2 ZEB1 LRCH2 SLC35F1 TNS1

2.99e-051782207185b44700f06ec58b3c09c80520502166c965fd6
ToppCellCOVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A CD109 TCAF2 ZEB1 SHANK3 IGFBP5 SH3RF3

3.09e-051792207754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCelldroplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADRA1D NRXN2 FAT3 WNT10B SLC35F1 SLC6A2 CSMD1

3.09e-051792207dfd9d29281510d32f1a2e8336d2e58ef496cfd1d
ToppCellCOVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type

EPPK1 PPP1R12A ACTG2 SORT1 SDK1 TBX2 SH3RF3

3.09e-051792207a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCellCOVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

PDE2A CD109 ZEB1 SHANK3 IGFBP5 TNS1 SH3RF3

3.21e-051802207493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRKD3 FLNB WNT10B DNAH1 TBX18 IGFBP5 LRRN4CL

3.21e-051802207c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ACTG2 TMEM132A TNFRSF19 TBX2 ZEB1 IGFBP5 HR

3.32e-051812207d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A ITGA6 ZNF469 CPXM2 SHANK3 IGFBP5 SH3RF3

3.56e-051832207dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE2A ITGA6 ZNF469 CPXM2 SHANK3 IGFBP5 SH3RF3

3.56e-0518322074759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCelldroplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B ACTG2 TNFRSF19 HHIP IGFBP5 FAM13A CSMD1

3.56e-05183220719e7be1cfdd111bfb840532a6f7c780345dffccf
ToppCelldroplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B ACTG2 TNFRSF19 HHIP IGFBP5 FAM13A CSMD1

3.56e-051832207b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EPPK1 ITGA6 PANK1 MET PTPRZ1 LAMB4 HR

3.56e-051832207bbf27d2f4369031fadacacd6c432c06b1ec5abdb
ToppCellCOVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type

CD109 ITGA6 ZEB1 CPXM2 SHANK3 IGFBP5 SH3RF3

3.56e-051832207ff95382cfed592190d0636d2b750328471f82e0d
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

AK7 HMCN2 GRIN3A NPAS1 KCP TENM1 CDH7

3.69e-0518422077f6c8912677764d438ab0555faca344d74c2f483
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACTG2 HMCN2 NRXN2 GRIN3A HHIP IGFBP5 TNS1

3.69e-051842207590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCellCOVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAP1B HMCN2 PXDNL COL6A3 ZEB1 TBX18 LRP1

3.82e-0518522078f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCellfacs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B ACTG2 ADRA1D TIGAR LRCH2 HHIP IGFBP5

3.95e-051862207aa88d9573a237b2b8e6025fee31f69fbce824497
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

BDP1 HDAC4 UBASH3A UBTD1 TECPR1 STRN3 OPA1

3.95e-05186220774c238759c5d3fd39127ec0060d0c2cb16b326d4
ToppCellfacs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B ACTG2 ADRA1D TIGAR LRCH2 HHIP IGFBP5

3.95e-051862207ecc5acd111a6ee50d59544d1bdd7ed94e2812aae
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MAP1B ACTG2 SDK1 TBX2 SLC35F1 IGFBP5 CSMD1

3.95e-0518622074780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

KMT2C PLEC USH2A LAMB4 MED13L LRP1 CSMD1

3.95e-05186220723b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FBXO40 MAP1B CD109 ACTG2 ADRA1D PTPRZ1 TBX18

4.09e-051872207218c9b4f28499389c43005d9626af2ac01066027
ToppCellCOVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAP1B KAZN SDK1 COL6A3 C2CD2 TNS1 SH3RF3

4.09e-05187220776bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

BDP1 HDAC4 UBASH3A UBTD1 TECPR1 STRN3 ZEB1

4.09e-051872207816d37a70f7ec382a268fe828b3dfe737a36a4bf
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FBXO40 MAP1B CD109 ACTG2 ADRA1D PTPRZ1 TBX18

4.09e-051872207c7ac4b328efc2ebb72f71154661914193ff402ca
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LAMA1 KAZN STRN3 ZEB1 ZHX2 TENM1 TNS1

4.09e-051872207c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ACTG2 HMCN2 TNFRSF19 HHIP IGFBP5 DCHS1 HR

4.23e-051882207c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ABL2 MAP1B PTPRZ1 COL6A3 LRRN4CL LRP1 GASK1A

4.23e-0518822071cd5a4d744bd3777246958ea5eb94388a5cbad81
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ABL2 MAP1B PTPRZ1 COL6A3 LRRN4CL LRP1 GASK1A

4.23e-051882207c32d023a69b6da79687ff8fa7485e7499db57046
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HMCN2 GRIN3A COL6A3 ZEB1 TBX18 HHIP LRP1

4.23e-051882207ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX3 TRIO PTPRZ1 GRIN3A SLC35F1 LRP1 CSMD1

4.23e-051882207a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SOX3 TRIO PTPRZ1 GRIN3A SLC35F1 LRP1 CSMD1

4.23e-051882207c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCHS2 NRXN2 KAZN COL6A3 IGFBP5 LRRN4CL LRP1

4.37e-051892207f7d57723b8fb0f1e1485f51e3eff93ec0f39761e
ToppCellCOVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type

MET FAT2 PTPRZ1 FLNB SHROOM3 TRIM2 NBEA

4.37e-05189220784d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCelldroplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE2A GPR146 NRXN2 TBX2 ZEB1 SHANK3 DCHS1

4.37e-051892207ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B SPTB SPTBN2 FAT2 NRXN2 TMEM132A SPTBN4

4.37e-051892207f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPTBN2 ITGA6 SDK1 VWA5B1 MOCOS TBX2 SHROOM3

4.37e-051892207532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B ACTG2 HMCN2 COL6A3 CPXM2 SLC35F1 TBX18

4.52e-0519022072e88e366d377d74deb53a4ea870973ce5c6532e8
DiseaseIntellectual Disability

UBA5 HDAC4 MAP1B TRIO PPP1R12A LAMA1 KIF4A QRICH1 KMT2C NRXN2 DHCR7 NBEA GRIN2D MED13L SHANK3

1.02e-0644721315C3714756
Diseasespinocerebellar ataxia type 5 (implicated_via_orthology)

SPTB SPTBN2 SPTBN4

1.48e-0642133DOID:0050882 (implicated_via_orthology)
DiseaseSchizophrenia

HDAC4 SPTBN2 LAMA1 BCL9 JARID2 MET ADSS2 NRXN2 PTPRZ1 DLG3 GRIN3A NPAS1 GRIN2D SHANK3 OPA1 SLC6A2 LRP1 ATM ZKSCAN4 CSMD1

7.11e-0688321320C0036341
Diseasedescending aortic diameter

FLNB COL6A3 SPTBN4 TBX18 LRP1 DOT1L

4.37e-05882136EFO_0021788
DiseaseKleefstra syndrome 2 (implicated_via_orthology)

KMT2C KMT2D

5.19e-0522132DOID:0080598 (implicated_via_orthology)
DiseaseColorectal Carcinoma

ACAP1 MAP1B SPTBN2 LAMA1 CD109 KMT2C YAP1 DLG3 VPS18 CAD HHIP TENM1 DCHS1 LRP1 CDH7 HR

5.62e-0570221316C0009402
Diseasecortical thickness

CNBD1 SPTBN2 LAMA1 RREB1 WARS2 ZNF469 NEO1 DMRT3 MTMR3 PLEC ZNF438 NPM1 FLNB STRN3 SHROOM3 FAT3 MLLT10 HHIP LRP1 TNS1 SH3RF3

6.17e-05111321321EFO_0004840
DiseaseCataract

GALK1 DHCR7 MIP ATM

1.45e-04372134C0086543
DiseaseEpidermolysis bullosa with pyloric atresia

ITGA6 PLEC

1.55e-0432132C1856934
Diseaseautosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology)

TRIM2 TRIM3

1.55e-0432132DOID:0110282 (implicated_via_orthology)
Diseaseautosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology)

TRIM2 TRIM3

1.55e-0432132DOID:0110274 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

ACAP1 PDE2A HDAC4 CD109 YAP1 MTMR3 ZNF438 FLNB ZEB1 WNT10B GRIN2D SPAG6 KMT2D IGFBP5 GUCY2F TENM1 ATM TNS1 LRRFIP1

3.14e-04107421319C0006142
Diseasesmoking status measurement, chronic obstructive pulmonary disease

HDAC4 RREB1 FAM13A ZKSCAN4 TNS1

4.51e-04882135EFO_0000341, EFO_0006527
DiseasePseudoaphakia

GALK1 MIP ATM

6.71e-04242133C0524524
DiseaseLens Opacities

GALK1 MIP ATM

6.71e-04242133C1510497
Diseaserenal system measurement, uric acid measurement

NRXN2 PKD2

7.63e-0462132EFO_0004742, EFO_0004761
Diseasespontaneous preterm birth

SLC39A11 UBTD1 KAZN SDK1 TBX2

8.45e-041012135EFO_0006917
Diseaseautism spectrum disorder (implicated_via_orthology)

MET NRXN2 MOCOS NBEA SHANK3 SLC6A2

8.53e-041522136DOID:0060041 (implicated_via_orthology)
DiseaseSezary Syndrome

KMT2C ZEB1 KMT2D

9.55e-04272133C0036920
DiseaseDisorders of Sex Development

PPP1R12A DHCR7

1.06e-0372132C0036875
Diseaseataxia telangiectasia (is_implicated_in)

HDAC4 ATM

1.06e-0372132DOID:12704 (is_implicated_in)
Diseaseretinal detachment

FAT3 CDH7

1.06e-0372132EFO_0005773
Diseaseoral squamous cell carcinoma (is_marker_for)

MET KMT2D ARID2 ATM

1.13e-03632134DOID:0050866 (is_marker_for)
Diseasepulse pressure measurement

MAP1B RREB1 PRKD3 MET ADRA1D PXDNL YAP1 TBX2 ZNF438 FLNB COL6A3 SHROOM3 FAT3 NBEA MED13L SPTBN4 TBX18 FAM13A LRP1 AKAP13 DOT1L

1.20e-03139221321EFO_0005763
Diseaseepilepsy (implicated_via_orthology)

TRIO ITGA6 KIF4A GRIN2D CIT LRP1

1.22e-031632136DOID:1826 (implicated_via_orthology)
Diseasetriglyceride measurement, intermediate density lipoprotein measurement

HCP5 GPR146 BRWD1 SHROOM3 PCIF1

1.29e-031112135EFO_0004530, EFO_0008595
DiseaseHereditary spherocytosis

SPTB CAD

1.41e-0382132C0037889
Diseaseblindness (implicated_via_orthology)

PNPLA7 MYO15A

1.41e-0382132DOID:1432 (implicated_via_orthology)
Diseasecoloboma (implicated_via_orthology)

YAP1 PTCH2

1.41e-0382132DOID:12270 (implicated_via_orthology)
Diseasechronic obstructive pulmonary disease

DCHS2 HDAC4 RREB1 BCL9 MTMR3 COL6A3 HYKK VARS2 BTN2A1 FAM13A DOT1L ZKSCAN4 TNS1

1.57e-0368821313EFO_0000341
Diseaseresponse to lamotrigine

GRIN3A CSMD1

1.81e-0392132EFO_0007661
Diseaseretinal degeneration (is_implicated_in)

HDAC4 PKD2

1.81e-0392132DOID:8466 (is_implicated_in)
Diseasenon-syndromic X-linked intellectual disability (implicated_via_orthology)

ACSL3 DLG3

1.81e-0392132DOID:0050776 (implicated_via_orthology)
Diseaseneuroimaging measurement

DCHS2 MAP1B RREB1 WARS2 ZNF469 NEO1 DMRT3 PLEC ZNF438 STRN3 SHROOM3 FAT3 MLLT10 ZHX2 HHIP TNS1 SH3RF3

2.04e-03106921317EFO_0004346
DiseaseAcute Myeloid Leukemia, M1

TRIO MET KMT2C NPM1 MLLT10

2.18e-031252135C0026998
DiseaseAcute Myeloid Leukemia (AML-M2)

TRIO MET KMT2C NPM1 MLLT10

2.18e-031252135C1879321
Diseaseresponse to carboplatin, response to antineoplastic agent

FLNB CSMD1

2.25e-03102132GO_0097327, GO_0097328
Diseaseglucagon-like peptide-1 measurement

BICRA CSMD1

2.25e-03102132EFO_0008465
Diseasechronic obstructive pulmonary disease, chronic bronchitis

FAM13A CSMD1

2.25e-03102132EFO_0000341, EFO_0006505
Diseasebrain measurement, neuroimaging measurement

DCHS2 RREB1 WARS2 NEO1 PLEC ZNF438 FAT3 MLLT10 HHIP TNS1 SH3RF3

2.31e-0355021311EFO_0004346, EFO_0004464
Diseasehepatocyte growth factor-like protein measurement

NCKIPSD APEH DNAH1

2.60e-03382133EFO_0008154
Diseasebrain connectivity measurement

QRICH1 MET DMRT3 PLEC STRN3 HYKK FAT3 MLLT10 SH3RF3

2.63e-034002139EFO_0005210
Diseasethyrotoxic periodic paralysis

HCP5 TRIM2

2.73e-03112132MONDO_0019201
DiseaseNonsyndromic Deafness

BDP1 MET NARS2 MYO15A

2.85e-03812134C3711374
Diseaseintracranial aneurysm (is_implicated_in)

PKD2 KMT2D

3.26e-03122132DOID:10941 (is_implicated_in)
DiseaseAutism Spectrum Disorders

JARID2 NRXN2 USH2A SHANK3

3.39e-03852134C1510586
DiseaseBladder Neoplasm

HDAC4 KMT2C KMT2D IGFBP5 ATM

3.55e-031402135C0005695
DiseaseMalignant neoplasm of urinary bladder

HDAC4 KMT2C KMT2D IGFBP5 ATM

3.66e-031412135C0005684
DiseaseConnective Tissue Diseases

ZNF469 PKD2

3.84e-03132132C0009782
Diseasevital capacity

SPTBN2 RREB1 WARS2 MTMR3 VWA5B1 ZNF438 COL6A3 STRN3 SHROOM3 HYKK MLLT10 ZHX2 EML3 TBX18 HHIP FAM13A DOT1L TNS1

3.88e-03123621318EFO_0004312
Diseaseschizophrenia (is_marker_for)

GRIN2D OPA1 ELK1

3.95e-03442133DOID:5419 (is_marker_for)
DiseaseChagas cardiomyopathy

SPTB KAZN PLA2G4F

3.95e-03442133EFO_0005529
Diseasecognitive impairment measurement

PXDNL CSMD1 SH3RF3

3.95e-03442133EFO_0007998
DiseaseCleft palate, cleft lip

MAP1B POLR1G MTMR3 SDK1 SHROOM3 VIRMA ARID3B

4.30e-032792137EFO_0003959, HP_0000175
Diseasenevus count, cutaneous melanoma

HDAC4 JARID2 MED13L ATM

4.32e-03912134EFO_0000389, EFO_0004632
Diseaseresponse to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin

BCL9 CSMD1

4.46e-03142132EFO_0005400, GO_0036275, GO_1902518, GO_1902520
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

MET MLLT10 SPTBN4 AKAP13 ATM

4.49e-031482135C0279702
Diseasephotoreceptor cell layer thickness measurement

MAP1B RREB1 MTMR3 FAAP100 GDPD4

4.49e-031482135EFO_0803370
Diseaseresting heart rate

EPPK1 MET PLEC SLC35F1 CSMD1

4.62e-031492135EFO_0004351
DiseaseGastrointestinal Stromal Sarcoma

HHIP PTCH2 IHH

4.76e-03472133C3179349
Diseasepulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio

HDAC4 FAM13A LRP1

4.76e-03472133EFO_0003892, EFO_0004713, EFO_0005671
DiseaseNeuroblastoma

MET YAP1 TBX2

4.76e-03472133C0027819
DiseaseInguinal hernia

HDAC4 RREB1 HCP5 HMCN2 VARS2 BTN2A1 MUC22

5.01e-032872137HP_0000023
DiseaseSquamous cell carcinoma of esophagus

KMT2C FAT2 FAT3 KMT2D

5.04e-03952134C0279626
Diseasemean fractional anisotropy measurement

EPPK1 PLEC STRN3 MLLT10

5.04e-03952134EFO_0008399
DiseaseAnilide use measurement

HCP5 LRP1

5.12e-03152132EFO_0009938
DiseaseTinnitus, response to cisplatin

ADRA1D ZNF438

5.12e-03152132GO_0072718, HP_0000360
DiseaseGastrointestinal Stromal Tumors

HHIP PTCH2 IHH

5.66e-03502133C0238198
Diseasecognitive inhibition measurement

PXDNL USH2A MUC22

5.66e-03502133EFO_0007969
Diseaseresponse to thioamide, Drug-induced agranulocytosis

HCP5 MUC22

5.82e-03162132EFO_0007633, HP_0012235
Diseaseaspartate aminotransferase measurement

BDP1 MCMBP POLR1G HMCN2 KAZN CNTN2 MOCOS FLNB SHROOM3 MLLT10 FAM13A AKAP13 CSMD1 MYO15A

6.25e-0390421314EFO_0004736
Diseasecortical surface area measurement, neuroimaging measurement

RREB1 WARS2 STRN3 FAT3 HHIP SH3RF3

6.28e-032272136EFO_0004346, EFO_0010736
DiseaseBenign neoplasm of stomach

MET ATM

6.57e-03172132C0153943
DiseaseNeoplasm of uncertain or unknown behavior of stomach

MET ATM

6.57e-03172132C0496905
DiseaseCarcinoma in situ of stomach

MET ATM

6.57e-03172132C0154060
DiseaseAcute myeloid leukemia

NPM1 MLLT10

6.57e-03172132cv:C0023467
DiseaseLEUKEMIA, ACUTE MYELOID

NPM1 MLLT10

6.57e-03172132601626
Diseasepulmonary function measurement, FEV/FEC ratio

HDAC4 FAM13A LRP1

6.66e-03532133EFO_0003892, EFO_0004713
DiseaseC-reactive protein measurement

SP3 DCHS2 ORC3 RREB1 AK7 ZNF469 NEO1 CAD ZEB1 HYKK KCP GATC MIB2 MLLT10 CIT EML3 PCIF1

6.79e-03120621317EFO_0004458

Protein segments in the cluster

PeptideGeneStartEntry
GQVIPLAHTGSVETL

nan

76

Q8NBF4
VVHLITGSAPQSLGS

ARID3B

516

Q8IVW6
LHSQVDVGVVLADPG

CATSPERG

791

Q6ZRH7
ISSEQGDVGVCIIPH

BDP1

2001

A6H8Y1
GSAQVHIPSISVDGL

ELK1

401

P19419
GNEVPSQLASSGHIV

CSMD1

656

Q96PZ7
HTPADVQLIGTDSQG

ABL2

941

P42684
HASIEGPIANLSVLG

CFAP36

251

Q96G28
GALSIHNQEGATPVS

AKAP13

191

Q12802
SVIQGHQIIAVPDSG

ARID2

1476

Q68CP9
GIVLDSGDGVTHNVP

ACTG2

151

P63267
VQAESPFGVGALTHL

ARMC5

631

Q96C12
PGGVGHVVAQVQSVD

ACAP1

401

Q15027
LAVAGGVTQLPNHVV

ATF6

256

P18850
GVSSQGCVDHPIVLT

ACTR5

121

Q9H9F9
VPAAAGLVHVSSAAT

DOT1L

1501

Q8TEK3
CALTGPVVDIVTGHA

DHCR7

66

Q9UBM7
DHFVELNVGVTGLPV

BBS10

216

Q8TAM1
NSLTHVPGIGAVFQI

CIT

1621

O14578
SHGKGIPNAIISVEG

CPXM2

651

Q8N436
LHPAVSVGQATTVEI

MIP

121

P30301
SGPVHISGQHLVAVE

NPM1

106

P06748
TAAVVLLLSGVGPAH

NOMO3

16

P69849
GNIHIPVAVQAVAGT

QRICH1

391

Q2TAL8
SEHAVLIGAGIGITP

NOX5

581

Q96PH1
VSHVLSQAEGGQTPL

NPAS1

401

Q99742
SINASPGVVVDIAHG

PADI4

41

Q9UM07
EDVAPGTSVGIVQAH

DCHS1

801

Q96JQ0
HSVLGAAVSVGVPQG

DNAJC11

346

Q9NVH1
TAAVVLLLSGVGPAH

NOMO2

16

Q5JPE7
GGHDVLVTPQDVARI

LIPN

341

Q5VXI9
SGVHGAVLVLEPTFN

KAZN

636

Q674X7
EVVPLNIGGAHFTTR

KCTD7

51

Q96MP8
NDHVIDATLTGGPAR

KMT2C

4831

Q8NEZ4
VVLVSSGFDAVEGHP

HDAC4

926

P56524
NPRTLVHAAVGVGTA

LRRN4CL

191

Q8ND94
TVGAGVLHITENGPT

MAP1B

1671

P46821
DIPVPQSVASAGGHI

MED13L

291

Q71F56
PQGSGRITAAVIEHL

GATC

26

O43716
HTVPGIVLNTSGLGT

MUC22

1586

E2RYF6
HTVVLVDNLGGTEAP

LRR1

381

Q96L50
GHTAVVQELLESLPG

LRRK1

131

Q38SD2
GSVGTGVQLLAVSHV

MYO15A

2781

Q9UKN7
GTLHIEDAAVPGAQE

HDHD2

16

Q9H0R4
VHEFPSVSIIGGENI

HMCN2

1806

Q8NDA2
TVVSADLPNAHGLAV

LRP1

1651

Q07954
VSVNTLVLGHSEPGE

ARNTL2

466

Q8WYA1
AGAPHQVQGLVSTVS

HR

1121

O43593
AILESHGIDVQSPGG

HMBOX1

346

Q6NT76
VEPVNVVDNGDGTHT

FLNB

1466

O75369
NADEAVTIHPVTGSI

FAT2

1911

Q9NYQ8
NHVVDVSVAVSTPAG

DLAT

506

P10515
AGHVATTGQILNIPD

PDE2A

466

O00408
VFPLDIGVVGHVAQT

PDE6B

131

P35913
SLVVSPISQGLFHGA

CES2

236

O00748
LNSTGEVPVLIHGEN

GDAP1

71

Q8TB36
AVSAPGRVNLIGEHT

GALK1

31

P51570
ISVVPSNFIGHLSGL

NRXN2

871

Q9P2S2
LEGLPLTVSAVQGAH

NOL6

676

Q9H6R4
TAAVVLLLSGVGPAH

NOMO1

16

Q15155
EAAPVTGTGRVNLHE

HEATR6

341

Q6AI08
IAVQVRGGPSDHEAT

IGFBPL1

211

Q8WX77
GAQIISPHDKGISQA

PGM2

181

Q96G03
HNPVLAATGVGLDVA

PRKD3

506

O94806
SVAPGFQHVGRLVSI

GDPD4

376

Q6W3E5
SLQGTAPFLHVGAVA

GDPD5

156

Q8WTR4
VGGAENTAHPRIISA

IGFBP5

166

P24593
AAGVLEGALGPHVVT

MOCOS

571

Q96EN8
VSGAPRANHSGAVVL

ITGA6

316

P23229
SVPIGNGHVAITAVS

PTPRZ1

1366

P23471
TAHISDGGTPVLATN

PCDHGC3

536

Q9UN70
LQAVVAGVPGHSEAA

IRAK1

521

P51617
VPASEVITNGVLVAH

PLA2G4F

166

Q68DD2
AHVPQVSNVSATGEL

FAM13A

351

O94988
LSSIQGVAPDGANVH

FAAP100

751

Q0VG06
ALLHVPAGTVVSRQG

PNPLA7

476

Q6ZV29
LVSGHILSNSPVAAV

HCP5

101

Q6MZN7
TVAQEEPLSAHSVGV

LRRC66

541

Q68CR7
HTVVVQGVSALLAFP

GRIN3A

186

Q8TCU5
GGGLTAVINADVTIH

DCHS2

851

Q6V1P9
GAHTRAVAAIVVPAN

PRSS36

116

Q5K4E3
DHLPRVVVVGDQSAG

OPA1

286

O60313
GGQLPVEGQHTVLSS

PXDNL

456

A1KZ92
GVTGAPATHIRQALS

GASK1A

51

Q9UFP1
SSAPAVQVGTHRGLE

DNAH1

21

Q9P2D7
HVAVVVRPGNAGLTD

ENOPH1

226

Q9UHY7
GEVGPIDFSTIAIQH

ATM

1676

Q13315
ATGHQQTLLVPSEDG

CD109

801

Q6YHK3
VSHEADVGLAGVQLP

GCC1

61

Q96CN9
ESKSPIQVGGHVLAG

HYKK

276

A2RU49
IQVGGHVLAGFESIT

HYKK

281

A2RU49
VVGSSPGHPAVQVES

BICRAL

671

Q6AI39
SEPGASGHINAVCVV

C2CD2

276

Q9Y426
GTGLQGSLPVHVFEA

PCIF1

486

Q9H4Z3
GGICVANHTSPIDVI

GPAT4

241

Q86UL3
EQNHLLIEGPSGTVS

DMRT3

226

Q9NQL9
LDISVAGSQVHSPGI

BCL9

846

O00512
SHGLPVGVVLTTGQD

GUCY2F

211

P51841
SAGSRIEDGVPQHLV

COL6A3

1531

P12111
FPVGGHITAVSAIDI

FAT3

591

Q8TDW7
DIGHALVQIRTTGPG

CNTN2

976

Q02246
LVLVSGNHDIGNTPT

CPPED1

121

Q9BRF8
ARLVTPHGESEQIGV

DLG3

546

Q92796
APVAVLQGHTGSITS

BRWD1

261

Q9NSI6
ANGVTVPEEGLTLHR

BTN2A1

506

Q7KYR7
VDIGLVPHGLSATNG

FBXO40

176

Q9UH90
PHTGVTSQVLGVAAA

DEF8

26

Q6ZN54
AAVAFVEQGHVRVGP

IMP3

126

Q9NV31
LQAHGGTLPGSITVE

KIF4A

366

O95239
IPVATHLLNNGSGVG

KANSL3

306

Q9P2N6
TFGQSPAVHVVLGEP

LAMB4

571

A4D0S4
SLTFIGHQDIPGVGN

CENATAC

221

Q86UT8
VTAIEPIINHGGASA

AHCTF1

126

Q8WYP5
LAVHPDGVRVASGQT

EML3

311

Q32P44
DVAGNVVGVSVVTHP

EMC10

151

Q5UCC4
QVGNIIGTVAAHDPD

CDH7

391

Q9ULB5
SVGGEVHVALQIPFN

GPR146

96

Q96CH1
ANVGGQILAAAAPHT

BICRA

491

Q9NZM4
EAVAGSEAGAQLHPV

SDK1

2171

Q7Z5N4
ITIHNVPEGLAVGVG

SLC39A11

201

Q8N1S5
GLQPARVAAVSTHVA

IHH

311

Q14623
TEDVAVPEQGNAHIG

LRCH2

411

Q5VUJ6
VEEQAGTVASCPLGH

LRRFIP1

431

Q32MZ4
GQLDTPGVHNVTALS

MCMBP

466

Q9BTE3
SGVEEPAHRAGIEIQ

MTMR3

701

Q13615
EDVVHTLLQANGTPG

JARID2

961

Q92833
VTNLHVGAAPGPEAA

MIB2

816

Q96AX9
PVGTSAAAVNGLLHN

PANK1

156

Q8TE04
PTAALVLGVNVTDHD

ORC3

101

Q9UBD5
IGPSSLIVHFNEVIG

MET

1071

P08581
IGGTVSHEFQLPVDI

PARS2

251

Q7L3T8
PGSDHAGIATQAVVE

VARS2

181

Q5ST30
PAGRAGVSNIVAVHA

WARS2

266

Q9UGM6
VLLVHGVTLPGASNG

SLC6A2

276

P23975
IGVVAANHAGEILSP

USH2A

4041

O75445
EPNAVGIVIAHGSVG

SORT1

481

Q99523
GIVIAHGSVGDAISV

SORT1

486

Q99523
GGIIVAIEHSSRPIN

SORT1

531

Q99523
AHIGPVLSLAISSNG

STRN3

531

Q13033
QGAGTAVNGTVPLTH

SOX3

431

P41225
IPGLAASVLVVSHGA

TIGAR

186

Q9NQ88
HTPELSQLVVNAGGV

SPAG6

281

O75602
VVVSGAGAEGLPLHV

TMEM132A

726

Q24JP5
TGGVPSQLLVHGALA

TCAF2

231

A6NFQ2
AGHVGVVSVEFIAPA

NBR1

436

Q14596
QHTVAAVDLLVPGVG

NARS2

386

Q96I59
LLQDGAVTVDGHPVA

KCP

1281

Q6ZWJ8
LIVDGNAVGAESPHT

LAMA1

2991

P25391
PHTDSGIGEEQVASI

NBEA

1671

Q8NFP9
DGTVPVGIAHLTATV

PTCH2

586

Q9Y6C5
NSFIGHQLGGVVEVP

PTCHD4

146

Q6ZW05
EAQIATGGVIDPVHS

EPPK1

721

P58107
EAQVATGGIIDPTSH

EPPK1

1041

P58107
AQIATGGVIDPVHSH

EPPK1

2341

P58107
EAQIATGGVIDPVHS

EPPK1

2876

P58107
LEAQIATGGVIDPVH

EPPK1

3406

P58107
EAQIATGGVIDPVHS

EPPK1

3941

P58107
AQIATGGVIDPVHSH

EPPK1

4476

P58107
AGAQLIILEHAPATT

NEO1

421

Q92859
VVLGAHVLSTAEPTQ

PRSS57

86

Q6UWY2
VTEAPVTQEAVNGHG

POLR1G

181

O15446
AGPANVHLINSGVGV

SIX5

511

Q8N196
PGAAHVVGSQTLASR

SHROOM3

1586

Q8TF72
IDGTPLVGVNVSFLH

TENM1

896

Q9UKZ4
IGLSSEPHILAGAVN

TENM1

1736

Q9UKZ4
VTAFIGNGVVIHLPG

ADSS2

91

P30520
PEFATHGVAAVLAGT

SLC25A52

116

Q3SY17
EVVSGLRQPVGALHS

HHIP

221

Q96QV1
GIIVGHIQASVPASS

NCKIPSD

336

Q9NZQ3
GVNEADGTIHRPISV

SPATA1

161

Q5VX52
DSILSLPGNVGHQDV

APEH

546

P13798
SGHLQQVGALSPSAV

MLLT10

601

P55197
VIAVNSGGPLESIDH

ALG2

341

Q9H553
AVSLGVPHEVAEGAT

ADRA1D

541

P25100
ATLGGPAIVHALNET

ACSL3

191

O95573
SLAGHPVVAAQAAAV

ARID3A

416

Q99856
GHPQSVQLEEGLGTS

ANHX

281

E9PGG2
TAPHEATAGIIGVNR

CLTC

306

Q00610
GHVIVESGNIISFVG

CNBD1

346

Q8NA66
HVVTTIENLPAEGSG

SLC35F1

21

Q5T1Q4
TQAVRAVAFHPAGGL

WDR47

606

O94967
VGSSGLITQEGVHIP

ZNF653

231

Q96CK0
PVDHVGNATASQELG

TM2D2

86

Q9BX73
AGSVAAGVIQSPRHL

TRBV13

26

A0A0A6YYD4
HGEVPVSLARAQGSV

SPTBN2

2271

O15020
PAGLIVVHATSNGQE

SHANK3

1206

Q9BYB0
VVQTDSASPLGAGHL

TBX2

451

Q13207
HPILATADGASQLVG

RREB1

1671

Q92766
PVEGVHLLSSGGQQS

TBX18

571

O95935
LQGAVGPEVSSLSIH

SH3RF3

756

Q8TEJ3
AVSGHIQLIIPGESA

UBA5

211

Q9GZZ9
VNSIDSAGIQLHPGE

SP3

526

Q02447
GGHSVANLIEPVNIS

SPATA31D1

391

Q6ZQQ2
LHVGTDQPFASISIG

TECPR1

981

Q7Z6L1
STGPILVGTAQGHIF

VPS18

156

Q9P253
GTHAVVGVATALAPL

SPSB2

101

Q99619
VPAQVHVNGGALASE

TNS1

481

Q9HBL0
GVVSGPAATPTAQHL

YAP1

146

P46937
AVGPGADTVHLVGLA

SPTBN4

731

Q9H254
AVVLSCQVHTGVPEG

SIGLEC1

911

Q9BZZ2
GVNLAANSLVESGHP

SPTB

906

P11277
EAQAGTGHIIDPATS

PLEC

3196

Q15149
AQAILDGASITLPHG

UBTD1

86

Q9HAC8
AASQISHGLGTPVGL

PKD2

921

Q13563
LHETVAPSDIVGAGV

SLC35G6

301

P0C7Q6
ENAGVHSGDATLVTP

CAD

1156

P27708
AGLVDAGVTQSPTHL

TRBV5-6

16

A0A599
VTTLPAVAGHQLGLE

ZNF469

1936

Q96JG9
ASPIQQGGHSVISAI

ZEB1

446

P37275
QGGHSVISAISLPLV

ZEB1

451

P37275
AGPEILSNEHVGARA

ZEB1

1001

P37275
VVVNGHTEGPAPARS

ZNF598

631

Q86UK7
VIAIGESELSIHNGP

ZNF507

306

Q8TCN5
SPITLAVAGVTNHGQ

ZHX2

391

Q9Y6X8
IAQIPTHAEAGEQEG

ZKSCAN4

291

Q969J2
SSQDLVGGAVPVQSH

TNFRSF19

351

Q9NS68
PGILHSVSGGLQSAV

WNT1

76

P04628
IEVHIVATGTLPNGT

VSIG10

126

Q8N0Z9
PDVTASALQGLHIAV

WNT10B

66

O00744
SDQLTPQGHVAVAVG

YIPF2

31

Q9BWQ6
PQGLALTSDGHVVVA

TRIM2

716

Q9C040
LAVEGTNGIDNHVPT

WWP1

181

Q9H0M0
LITFNPVGRSAVGHV

VIRMA

801

Q69YN4
EHGGVAALPAQVVGQ

nan

101

Q6ZTI0
AGQEGTFSLVALPHV

ZNF438

86

Q7Z4V0
VLPNHSVGISLGQGA

ZMYND15

61

Q9H091
AGPVEAGVTQSPTHL

TRBV5-3

16

A0A0A0MS03
LGHTSAVIVENPDGT

TRIO

2611

O75962
PQGLALTSDGHVVVA

TRIM3

716

O75382
CPQDTGVILIVSHGS

UBASH3A

576

P57075
VTGNILQDGVSIAPH

VWA5B1

96

Q5TIE3
NNEHVIDATLTGGPA

KMT2D

5456

O14686
GTNVIPTIHVLDLAG

AK7

246

Q96M32
HVGAVNSEGDTPLDI

PPP1R12A

131

O14974
QTSLPIVAVHGGAAL

GRIN2D

136

O15399